Uploaded November 2026 | Updated November 2026, 1 day ago
The Food and Drug Administration is requiring GLP-1 agonist medications to carry a warning about a potential increased risk of a rare, serious eye condition.
FULL STORY: wishtv.com/news/health-spotlight/fda-requires-warning-on-glp-1-drugs-over-rare-eye-condition
——————————————————————————————
WISH-TV website | wishtv.com
Follow us!
facebook.com/WISHNews8
instagram.com/WISH8News
tiktok.com/@WISHNews8
twitter.com/WISHNews8
threads.net/@wish8news
https://bsky.app/wishtv.com
Download the WISH-TV App | bit.ly/3vMkd5q
Subscribe to the WISH-TV Newsletter | wishtv.com/email-alerts
Have a news tip? Email us at news@wishtv.com
The Food and Drug Administration is requiring GLP-1 agonist medications to carry a warning about a potential increased risk of a rare, serious eye condition.
FULL STORY: wishtv.com/news/health-spotlight/fda-requires-warning-on-glp-1-drugs-over-rare-eye-condition
——————————————————————————————
WISH-TV website | wishtv.com
Follow us!
facebook.com/WISHNews8
instagram.com/WISH8News
tiktok.com/@WISHNews8
twitter.com/WISHNews8
threads.net/@wish8news
https://bsky.app/wishtv.com
Download the WISH-TV App | bit.ly/3vMkd5q
Subscribe to the WISH-TV Newsletter | wishtv.com/email-alerts
Have a news tip? Email us at news@wishtv.com










